Literature DB >> 17564425

Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis.

Yongxia Yang1, Chenglong Li, Xiu Nie, Xiansong Feng, Wenxue Chen, Yong Yue, Huiru Tang, Feng Deng.   

Abstract

High-resolution magic-angle spinning (MAS) 1H nuclear magnetic resonance spectroscopy has been employed to characterize the metabolite composition (i.e., metabonome) of the human hepatocellular carcinoma (HCC) tumor in combination with principal component analysis (PCA). The results showed that (a) the metabonomes of both low-grade HCC and high-grade HCC tumors differ markedly from that of the adjacent non-involved tissues; and (b) low-grade HCC tumors have clear differences in metabonome from that of the high-grade HCC tumors. Compared with the non-involved adjacent liver tissues, HCC tumors had elevated levels of lactate, glutamate, glutamine, glycine, leucine, alanine, choline metabolites, and phosphorylethanolamine (PE), but declined levels of triglycerides, glucose, and glycogen. The levels of lactate, amino acids including glutamate, glutamine, glycine, leucine and alanine, choline and phosphorylethanolamine (PE) were higher but the levels of PC, GPC, triglycerides, glucose, and glycogen were lower in high-grade HCC than in low-grade HCC tumors. Compared with non-cirrhotic, low-grade HCC tumors, the cirrhotic, low-grade HCC tumors showed statistically significant increases in lactate, phosphocholine (PC), and glycerophosphocholine (GPC). The necrosis in HCC tumors resulted in a drastic increase in the levels of observable triglycerides, signals of which dominated their 1H NMR spectra. These results indicated that HRMAS combined with PCA offers a useful tool for understanding the tumor biochemistry and classification of liver tumor tissues; such tool may also have some potential for liver tumor diagnosis and prognosis even when some other disease processes are present.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17564425     DOI: 10.1021/pr070063h

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  75 in total

1.  Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.

Authors:  Tianlu Chen; Guoxiang Xie; Xiaoying Wang; Jia Fan; Yunping Qiu; Xiaojiao Zheng; Xin Qi; Yu Cao; Mingming Su; Xiaoyan Wang; Lisa X Xu; Yun Yen; Ping Liu; Wei Jia
Journal:  Mol Cell Proteomics       Date:  2011-04-25       Impact factor: 5.911

2.  Minimization of spectral pattern changes during HRMAS experiments at 37 degrees celsius by prior focused microwave irradiation.

Authors:  Myriam Davila; Ana Paula Candiota; Martí Pumarola; Carles Arus
Journal:  MAGMA       Date:  2012-10       Impact factor: 2.310

3.  (1)H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis.

Authors:  Juan Wang; Shu Zhang; Zongfang Li; Jun Yang; Chen Huang; Rongrui Liang; Zhongwei Liu; Rui Zhou
Journal:  Tumour Biol       Date:  2010-10-04

Review 4.  Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications.

Authors:  Roland Amathieu; Mohamed Nawfal Triba; Corentine Goossens; Nadia Bouchemal; Pierre Nahon; Philippe Savarin; Laurence Le Moyec
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

5.  Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma.

Authors:  Shu-Ye Liu; Rikki-Lei Zhang; Hua Kang; Zhi-Juan Fan; Zhi Du
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

Review 6.  Magnetic Resonance Spectroscopy: Principles and Techniques: Lessons for Clinicians.

Authors:  Joshua M Tognarelli; Mahvish Dawood; Mohamed I F Shariff; Vijay P B Grover; Mary M E Crossey; I Jane Cox; Simon D Taylor-Robinson; Mark J W McPhail
Journal:  J Clin Exp Hepatol       Date:  2015-11-12

7.  Is higher lactate an indicator of tumor metastatic risk? A pilot MRS study using hyperpolarized (13)C-pyruvate.

Authors:  He N Xu; Stephen Kadlececk; Harrilla Profka; Jerry D Glickson; Rahim Rizi; Lin Z Li
Journal:  Acad Radiol       Date:  2014-02       Impact factor: 3.173

8.  Visualization of bile homeostasis using (1)H-NMR spectroscopy as a route for assessing liver cancer.

Authors:  G A Nagana Gowda; Narasimhamurthy Shanaiah; Amanda Cooper; Mary Maluccio; Daniel Raftery
Journal:  Lipids       Date:  2008-11-04       Impact factor: 1.880

Review 9.  The metabolomic window into hepatobiliary disease.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  J Hepatol       Date:  2013-05-25       Impact factor: 25.083

Review 10.  Metabolomics-based methods for early disease diagnostics.

Authors:  G A Nagana Gowda; Shucha Zhang; Haiwei Gu; Vincent Asiago; Narasimhamurthy Shanaiah; Daniel Raftery
Journal:  Expert Rev Mol Diagn       Date:  2008-09       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.